20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2010 | S0859 | Others | |
S0859 is an N-cyanosulphonamide that blocks the sodium/bicarbonate cotransporter (NBC, also known as SLC4A7), which regulates intracellular pH. | |||
T38843 | Enavogliflozin | DWP-16001 | SGLT |
Enavogliflozin (DWP-16001) is an orally available small molecule and sodium glucose transporter 2 inhibitor. | |||
T17243 | VU0463271 | N-Cyclopropyl-N-(4-methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide | Potassium Channel |
VU0463271 (N-Cyclopropyl-N-(4-methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide) is a potent and selective antagonist of the neuronal-specific potassium-chloride cotransporter 2 (KCC2), with an IC50 of 61 nM ... | |||
TQ0011 | PF-06869206 | Sodium Channel | |
PF-06869206 is an oral selective inhibitor of the sodium-phosphate cotransporter NaPi2a (SLC34A1, IC50: 380 nM). | |||
T5444 | CLP290 | CLP-290 | Potassium Channel |
CLP290 is an activator of the neuron-specific K+-Cl cotransporter KCC2 and displays potential for the treatment of a wide range of neurological and psychiatric indications. | |||
TQ0139 | VU 0240551 | N-(4-Methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide,VU0240551-2-D4 | Potassium Channel , Calcium Channel , HER |
VU 0240551 is a selective antagonist of neuronal K-Cl cotransporter KCC2 inhibitor with an IC50 of 560 nM. VU 0240551 inhibits L-type calcium channels and hERG. | |||
T4999 | Ertugliflozin | MK-8835,PF-04971729 | SGLT |
PF-04971729 (Ertugliflozin (PF-04971729)) is a potent and selective inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2). | |||
T14984 | CLP257 | Potassium Channel | |
CLP257 is a selective K+-Cl− cotransporter KCC2 activator (EC50: 616 nM) and it is inactive against NKCC1, GABAA receptors, KCC1, KCC3 or KCC4. CLP257 alleviates hypersensitivity in rats with neuropathic painc and it al... | |||
T4564 | Ethacrynic acid | Edecrin,Etacrynic Acid,Hydromedin | Others , Calcium Channel , NF-κB , GST |
Ethacrynic acid (Edecrin) is a nonsulfonamide loop diuretic that inhibits the activity of the Na+/K+/2Cl- cotransporter NKCC2 in the thick ascending limb of the loop of Henle. It also inhibits glutathione S-transferase a... | |||
T35336 | Furosemide sodium | Frusemide Sodium,Lasix | Na-K-Cl cotransporter |
Furosemide sodium (Frusemide Sodium) is a potent and orally active inhibitor of Na+/K+/2Cl- (NKCC) cotransporter, NKCC1 and NKCC2. Furosemide sodium is also a GABAA receptors antagonist and displays 100-fold selectivity ... | |||
T11528 | H100 | Others | |
H100 is a Cl- transport inhibitor, no effect against KCl cotransporter. It has partial effects against both the NaK2Cl cotransporter and the Band 3 anion exchanger. | |||
T16818 | S-8921 | Others | |
S-8921 is an inhibitor of ileal Na+/bile acid cotransporter. | |||
T17221 | Velagliflozin | SGLT | |
Velagliflozin is an orally available inhibitor of sodium-glucose cotransporter 2. | |||
T30534 | BMS-639432 | ||
BMS-639432 is a potent sodium-glucose cotransporter type II (SGLT2) inhibitor. | |||
T15752 | Licogliflozin | LIK066 | SGLT |
Licogliflozin (LIK066) is an inhibitor of sodium-glucose cotransporter (SGLT1 and SGLT2). | |||
TN1842 | Kushenol I | GABA Receptor , Antifection | |
Kushenol I is a GABAA receptor modulator, it exhibits inhibitory activity against Sodium-dependent glucose cotransporter 2(SGLT2).Kushenol I is shown to be active against the plant pathogenic fungus Cladosporium cucumeri... | |||
T21399 | Luseogliflozin | TS71,TS-071,TS 71,TS071,TS-71,TS 071 | |
Luseogliflozin, a potent and competitive inhibitor of sodium-dependent glucose cotransporter 2 (SGLT2), competitively inhibits human SGLT2-mediated glucose uptake with a Ki value of 1.10 nM. | |||
T28971 | Tianagliflozin | ||
Tianagliflozin, a sodium/glucose cotransporter 2 (SGLT-2) inhibitor, is used potentially for the treatment of type 2 diabetes. | |||
T15797 | LX2761 | Others | |
LX2761 is a chemically stable and effective inhibitor against sodium-dependent glucose cotransporter 1 (SGLT1) and SGLT2 (IC50s: 2.2 nM and 2.7nM for hSGLT1 and hSGLT2). However, it shows specific SGLT1 inhibition in the... | |||
T12892 | SGL5213 | SGLT | |
SGL5213 is an oral active and low-absorbable inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1)(hSGLT1 and hSGLT2 with IC50 values of 29 nM and 20 nM , respectively),and has potential to treat type 2 diabetes. |